Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Integrative Cancer Therapies|November 29, 2021
Topical Cannabinoids for Treating Chemotherapy-Induced Neuropathy: A Case SeriesStacy D'Andre, Sean McAllister, Jasdeepa Nagi, et al.Frontiers in Oncology|December 19, 2022
BPTF promotes the progression of distinct subtypes of breast cancer and is a therapeutic targetVladimir Bezrookove, Imran A Khan, Mehdi Nosrati, et al.Plos One|January 23, 2026
HEDGES co-prevents both SARS-CoV-2 and pandemic influenza infection in mice by rapid, durable co-production of twelve different anti-pandemic monoclonal antibodiesMarissa Mack, Alice Ye, Sarah Ursu, et al.Oncotarget|March 25, 2014
HCMV glycoprotein B is expressed in primary glioblastomas and enhances growth and invasiveness via PDGFR-alpha activationCharles Cobbs, Sabeena Khan, Lisa Matlaf, et al.Cancers|September 10, 2021
Niraparib Suppresses Cholangiocarcinoma Tumor Growth by Inducing Oxidative and Replication StressVladimir Bezrookove, John M Patino, Mehdi Nosrati, et al.Bioscience Reports|October 22, 2021
Multifunctionality of prostatic acid phosphatase in prostate cancer pathogenesisEvgenia Alpert, Armin Akhavan, Arie Gruzman, et al.Bioscience Reports|October 4, 2021
Multifunctionality of Prostatic Acid Phosphatase in Prostate Cancer PathogenesisEvgenia Alpert, Armin Akhavan, Arie Gruzman, et al.Journal of Medicinal Chemistry|September 29, 2006
Biarylpyrazole inverse agonists at the cannabinoid CB1 receptor: importance of the C-3 carboxamide oxygen/lysine3.28(192) interactionDow Hurst, Uju Umejiego, Diane Lynch, et al.Scientific Reports|October 29, 2020
Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses cholangiocarcinoma growth by targeting CDK2/5/9Hera Saqub, Hannah Proetsch-Gugerbauer, Vladimir Bezrookove, et al.Molecular Pharmacology|November 20, 2012
CB(1) receptor allosteric modulators display both agonist and signaling pathway specificityGemma L Baillie, James G Horswill, Sharon Anavi-Goffer, et al.Pageof 2